UroSEEK gene panel for bladder cancer surveillance

Affiliations

Editorial

Regan Wong et al. Transl Androl Urol. 2019 Dec.

. 2019 Dec;8(Suppl 5):S546-S549.

doi: 10.21037/tau.2019.12.41.

¹ Department of Surgery & Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest: Charles J. Rosser is an officer for the Nonagen Bioscience Corp. R Wong has no conflicts of interest to declare.

Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma.
Eich ML, Rodriguez Pena MDC, Springer SU, Taheri D, Tregnago AC, Salles DC, Bezerra SM, Cunha IW, Fujita K, Ertoy D, Bivalacqua TJ, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Netto GJ. Eich ML, et al. Mod Pathol. 2019 Oct;32(10):1544-1550. doi: 10.1038/s41379-019-0276-y. Epub 2019 Apr 25. Mod Pathol. 2019. PMID: 31028363 Free PMC article.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7-34. 10.3322/caac.21551 - DOI - PubMed
1. Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47. 10.3322/canjclin.52.1.23 - DOI - PubMed
1. IARC. The Global Cancer Observatory (GCO) is an interactive web-based platform presenting global cancer statistics to inform cancer control and research. Available online: http://globocan.iarc.fr/Pages/summary_table_site_sel.aspx
1. Hall MC, Chang SS, Dalbagni G, et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 2007;178:2314-30. 10.1016/j.juro.2007.09.003 - DOI - PubMed
1. Cancer Genome Atlas Research Network Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014;507:315-22. 10.1038/nature12965 - DOI - PMC - PubMed